Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Hiu Nam Tse, Ray Borrow & Peter D. Arkwright. (2020) Immune Response and Safety of Viral Vaccines in Children with Autoimmune Diseases on Immune Modulatory Drug Therapy. Expert Review of Vaccines 19:12, pages 1115-1127.
Read now
Read now
Eleftherios Pelechas, Paraskevi V Voulgari & Alexandros A Drosos. (2019) Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis. Therapeutics and Clinical Risk Management 15, pages 1073-1079.
Read now
Read now
Yoshiya Tanaka, Tsutomu Takeuchi, Masayoshi Harigai, Hisashi Yamanaka, Toshikazu Nakano, Koshiro Akagi, Yoshifumi Ukyo & Benjamin Hsu. (2019) Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: Subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T). Modern Rheumatology 29:2, pages 306-313.
Read now
Read now
Nguyen Quoc Vuong, Vu Van Chien, Do Thi Thao, Nguyen Thi Nga, Do Thi Phuong, Pham Van Cuong & Nguyen Tien Dat. (2018) The in vitro and in vivo anti-inflammatory activities of alphitonin-4-O-β-D-glucopyranoside. Natural Product Research 32:22, pages 2717-2719.
Read now
Read now
Geng Wang, Rong Mu & Huji Xu. (2015) Management of rheumatoid arthritis in People’s Republic of China – focus on tocilizumab and patient considerations. International Journal of General Medicine 8, pages 187-194.
Read now
Read now
Narendran Gopalan, Bruno Bezerril Andrade & Soumya Swaminathan. (2014) Tuberculosis-immune reconstitution inflammatory syndrome in HIV: from pathogenesis to prediction. Expert Review of Clinical Immunology 10:5, pages 631-645.
Read now
Read now
Shunsuke Mori, Kaoru Terada & Yukitaka Ueki. (2012) Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms. Modern Rheumatology 22:4, pages 515-523.
Read now
Read now
Articles from other publishers (61)
Aleksandra Zielińska, Piotr Eder, Jacek Karczewski, Marlena Szalata, Szymon Hryhorowicz, Karolina Wielgus, Milena Szalata, Agnieszka Dobrowolska, Atanas G. Atanasov, Ryszard Słomski & Eliana B. Souto. (2023) Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review. Frontiers in Immunology 14.
Crossref
Crossref
Rosa Méndez Hernández & Fernando Ramasco Rueda. (2023) Biomarkers as Prognostic Predictors and Therapeutic Guide in Critically Ill Patients: Clinical Evidence. Journal of Personalized Medicine 13:2, pages 333.
Crossref
Crossref
Cristina Mussini, Alessandro Cozzi-Lepri, Marianna Meschiari, Erica Franceschini, Giulia Burastero, Matteo Faltoni, Giacomo Franceschi, Vittorio Iadisernia, Sara Volpi, Andrea Dessilani, Licia Gozzi, Jacopo Conti, Martina Del Monte, Jovana Milic, Vanni Borghi, Roberto Tonelli, Lucio Brugioni, Elisa Romagnoli, Antonello Pietrangelo, Elena Corradini, Massimo Girardis, Stefano Busani, Andrea Cossarizza, Enrico Clini & Giovanni Guaraldi. (2023) Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study. Viruses 15:2, pages 294.
Crossref
Crossref
Giovanna Fico, Ulker Isayeva, Michele De Prisco, Vincenzo Oliva, Brisa Solè, Laura Montejo, Iria Grande, Nestor Arbelo, Marta Gomez-Ramiro, Luis Pintor, Bernardo Carpiniello, Mirko Manchia, Eduard Vieta & Andrea Murru. (2023) Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis. European Neuropsychopharmacology 66, pages 30-44.
Crossref
Crossref
Djamila MERGHACHE. (2022) The main treatments used for SARS-CoV-2 patients. Algerian Journal of Biosciences 3:2, pages 095-103.
Crossref
Crossref
Yoshiaki Sato, Ikuo Kashiwakura, Masaru Yamaguchi, Hironori Yoshino, Takeshi Tanaka, Ken Ikeda, Zhengmao Ye, Hirotsugu Komatsu, Takao Matsuzaki & Masato Hosoda. (2022) Discovery of a Novel Small-molecule Interleukin-6 Inhibitor Through
Virtual Screening Using Artificial Intelligence. Medicinal Chemistry 18:6, pages 694-700.
Crossref
Crossref
Gerd R Burmester, Vivian P Bykerk, Maya H Buch, Yoshiya Tanaka, Hideto Kameda, Amy Praestgaard, Hubert van Hoogstraten, Antonio Fernandez-Nebro & Thomas Huizinga. (2022)
Sarilumab monotherapy
vs
sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis
. Rheumatology 61:6, pages 2596-2602.
Crossref
Crossref
Aaliya L. Ali, Namrata P. Nailwal & Gaurav M. Doshi. (2022) Emerging Role of Interleukins for the Assessment and Treatment of Liver
Diseases. Endocrine, Metabolic & Immune Disorders - Drug Targets 22:4, pages 371-382.
Crossref
Crossref
André F. Rendeiro, Charles Kyriakos Vorkas, Jan Krumsiek, Harjot K. Singh, Shashi N. Kapadia, Luca Vincenzo Cappelli, Maria Teresa Cacciapuoti, Giorgio Inghirami, Olivier Elemento & Mirella Salvatore. (2022) Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment. Frontiers in Immunology 12.
Crossref
Crossref
Yuan Tian, Lindsay N. Carpp, Helen E. R. Miller, Michael Zager, Evan W. Newell & Raphael Gottardo. (2021) Single-cell immunology of SARS-CoV-2 infection. Nature Biotechnology 40:1, pages 30-41.
Crossref
Crossref
Sriram Kumar, Duygu Merve Çalışkan, Josua Janowski, Aileen Faist, Beate Claudine Gisela Conrad, Julius Lange, Stephan Ludwig & Linda Brunotte. (2021) Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics. Frontiers in Immunology 12.
Crossref
Crossref
Manju Silu, Navneet Prasad Mathur, Rekha Kumari & Pallavi Chaudhary. (2021) Correlation Between Anosmia and Severity Along with Requirement of Tocilizumab in COVID-19 Patients. Indian Journal of Otolaryngology and Head & Neck Surgery 73:3, pages 378-382.
Crossref
Crossref
Quentin Miagoux, Vidisha Singh, Dereck de Mézquita, Valerie Chaudru, Mohamed Elati, Elisabeth Petit-Teixeira & Anna Niarakis. (2021) Inference of an Integrative, Executable Network for Rheumatoid Arthritis Combining Data-Driven Machine Learning Approaches and a State-of-the-Art Mechanistic Disease Map. Journal of Personalized Medicine 11:8, pages 785.
Crossref
Crossref
Thao Quyen Cao, Nguyen Viet Phong, Jang Hoon Kim, Dan Gao, Hoang Le Tuan Anh, Viet-Duc Ngo, Le Ba Vinh, Young Sang Koh & Seo Young Yang. (2021) Inhibitory Effects of Cucurbitane-Type Triterpenoids from Momordica charantia Fruit on Lipopolysaccharide-Stimulated Pro-Inflammatory Cytokine Production in Bone Marrow-Derived Dendritic Cells. Molecules 26:15, pages 4444.
Crossref
Crossref
Rebecca Dowey, Ahmed Iqbal, Simon R. Heller, Ian Sabroe & Lynne R. Prince. (2021) A Bittersweet Response to Infection in Diabetes; Targeting Neutrophils to Modify Inflammation and Improve Host Immunity. Frontiers in Immunology 12.
Crossref
Crossref
Fazli Azim, Md Shahidul Islam, Hedaeytullah Saju, Kaniz Fatema, Aneela Hayat, Mostofa Kamal, Md Sarfraz, Nawshad Muhammad & Syed A.A. Rizvi. (2021) The Emergence of Novel Coronavirus Disease, Global Treatment Update and its Containment Strategies in Overpopulated Countries: A Review. Coronaviruses 2:5, pages 1-10.
Crossref
Crossref
Feras Jirjees, Ali K Saad, Zahraa Al Hano, Taher Hatahet, Hala Al Obaidi & Yahya H Dallal Bashi. (2021) COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic?. Infectious Disease Reports 13:2, pages 259-284.
Crossref
Crossref
Laurel E. Hind, Morgan A. Giese, Taylor J. Schoen, David J. Beebe, Nancy Keller & Anna Huttenlocher. (2020) Immune Cell Paracrine Signaling Drives the Neutrophil Response to A. fumigatus in an Infection-on-a-Chip Model. Cellular and Molecular Bioengineering 14:2, pages 133-145.
Crossref
Crossref
Cristina Mussini, Marco Falcone, Silvia Nozza, Caterina Sagnelli, Roberto Parrella, Marianna Meschiari, Nicola Petrosillo, Claudio Mastroianni, Antonio Cascio, Chiara Iaria, Massimo Galli, Antonio Chirianni, Evangelista Sagnelli, Carmelo Iacobello, Giovanni Di Perri, Francesco Mazzotta, Giampiero Carosi, Marco Tinelli, Paolo Grossi, Orlando Armignacco, Vincenzo Portelli, Massimo Andreoni & Marcello Tavio. (2021) Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT). Clinical Microbiology and Infection 27:3, pages 389-395.
Crossref
Crossref
Cristina Mussini, Alessandro Cozzi-Lepri, Marianna Menozzi, Marianna Meschiari, Erica Franceschini, Jovana Milic, Lucio Brugioni, Antonello Pietrangelo, Massimo Girardis, Andrea Cossarizza, Roberto Tonelli, Enrico Clini, Marco Massari, Michele Bartoletti, Anna Ferrari, Anna Maria Cattelan, Paola Zuccalà, Miriam Lichtner, Roberto Rossotti, Enrico Girardi, Emanuele Nicastri, Massimo Puoti, Andrea Antinori, Pierluigi Viale & Giovanni Guaraldi. (2021) Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLOS ONE 16:2, pages e0247275.
Crossref
Crossref
André F Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, Harjot Singh, Ayana Morales, Robert A DeSimone, Grant B Ellsworth, Rosemary Soave, Shashi N Kapadia, Kohta Saito, Christopher D Brown, JingMei Hsu, Christopher Kyriakides, Steven Chiu, Luca Vincenzo Cappelli, Maria Teresa Cacciapuoti, Wayne Tam, Lorenzo Galluzzi, Paul D Simonson, Olivier Elemento, Mirella Salvatore & Giorgio Inghirami. (2021) Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression. Life Science Alliance 4:2, pages e202000955.
Crossref
Crossref
Kevin DzoboHarry ChiririwaCollet DandaraWitness Dzobo. (2021) Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine. OMICS: A Journal of Integrative Biology 25:1, pages 13-22.
Crossref
Crossref
Erica Bacca, Margherita Digaetano, Marianna Meschiari, Erica Franceschini, Marianna Menozzi, Gianluca Cuomo & Cristina Mussini. (2021) Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature. Biochemical and Biophysical Research Communications 538, pages 151-155.
Crossref
Crossref
Jingwen Xu, Lei Zhou, Lianlian Sun, Zhe Wang, Yi Wang, Yihai Wang & Xiangjiu He. (2020)
3α-Angeloyloxy-
ent
-kaur-16-en-19-oic Acid Isolated from
Wedelia trilobata
L. Alleviates Xylene-Induced Mouse Ear Edema and Inhibits NF-κB and MAPK Pathway in LPS-Stimulated Macrophages
. Journal of Natural Products 83:12, pages 3726-3735.
Crossref
Crossref
Ryan Brown, Sridesh Nath, Alnardo Lora, Ghassan Samaha, Ziyad Elgamal, Ryan Kaiser, Clifford Taggart, Sinéad Weldon & Patrick Geraghty. (2020) Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics. Respiratory Research 21:1.
Crossref
Crossref
Jan Mares & Hans-Peter Hartung. (2020) Multiple sclerosis and COVID-19. Biomedical Papers 164:3, pages 217-225.
Crossref
Crossref
Giovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi-Lepri, Jovana Milic, Roberto Tonelli, Marianna Menozzi, Erica Franceschini, Gianluca Cuomo, Gabriella Orlando, Vanni Borghi, Antonella Santoro, Margherita Di Gaetano, Cinzia Puzzolante, Federica Carli, Andrea Bedini, Luca Corradi, Riccardo Fantini, Ivana Castaniere, Luca Tabbì, Massimo Girardis, Sara Tedeschi, Maddalena Giannella, Michele Bartoletti, Renato Pascale, Giovanni Dolci, Lucio Brugioni, Antonello Pietrangelo, Andrea Cossarizza, Federico Pea, Enrico Clini, Carlo Salvarani, Marco Massari, Pier Luigi Viale & Cristina Mussini. (2020) Tocilizumab in patients with severe COVID-19: a retrospective cohort study. The Lancet Rheumatology 2:8, pages e474-e484.
Crossref
Crossref
Bruno V S Valiate, Rodrigo U Alvarez, Laila Karra, Celso M Queiroz-Júnior, Flavio A Amaral, Francesca Levi-Schaffer & Mauro M Teixeira. (2019) The immunoreceptor CD300a controls the intensity of inflammation and dysfunction in a model of Ag-induced arthritis in mice. Journal of Leukocyte Biology 106:4, pages 957-966.
Crossref
Crossref
Marcin Smreczak, Anna Marzec, Anna Orłowska, Paweł Trębas, Michał Reichert, Anna Kycko, Penelopa Koraka, Ab Osterhaus & Jan Franciszek Żmudziński. (2019) The effect of selected molecules influencing the detrimental host immune response on a course of rabies virus infection in a murine model. Vaccine 37:33, pages 4715-4723.
Crossref
Crossref
N. Jung, J.-L. Bueb, F. Tolle & S. Bréchard. (2019) Regulation of neutrophil pro-inflammatory functions sheds new light on the pathogenesis of rheumatoid arthritis. Biochemical Pharmacology 165, pages 170-180.
Crossref
Crossref
Jesse Pace, Praharshasai Paladugu, Bhaskar Das, John C. He & Sandeep K. Mallipattu. (2019) Targeting STAT3 signaling in kidney disease. American Journal of Physiology-Renal Physiology 316:6, pages F1151-F1161.
Crossref
Crossref
Yoshiki Tsubosaka, Toko Maehara, Daiki Imai, Tatsuro Nakamura, Koji Kobayashi, Nanae Nagata, Wataru Fujii & Takahisa Murata. (2019)
Hematopoietic prostaglandin D synthase–derived prostaglandin D
2
ameliorates adjuvant‐induced joint inflammation in mice
. The FASEB Journal 33:6, pages 6829-6837.
Crossref
Crossref
S I Aqel, E E Kraus, N Jena, V Kumari, M C Granitto, L Mao, M F Farinas, E Y Zhao, G Perottino, W Pei, A E Lovett-Racke, M K Racke, J R Fuchs, C Li & Y Yang. (2019) Novel small molecule IL-6 inhibitor suppresses autoreactive Th17 development and promotes Treg development. Clinical and Experimental Immunology 196:2, pages 215-225.
Crossref
Crossref
Catalina Burbano, Mauricio Rojas, Carlos Muñoz-Vahos, Adriana Vanegas-García, Luis A. Correa, Gloria Vásquez & Diana Castaño. (2018) Extracellular vesicles are associated with the systemic inflammation of patients with seropositive rheumatoid arthritis. Scientific Reports 8:1.
Crossref
Crossref
Guillaume Desoubeaux, David CHAUVIN, Maria del Carmen Piqueras, Ellen BRONSON, Sanjoy K. BHATTACHARYA, Gayle SIRPENSKI, Eric BAILLY & Carolyn CRAY. (2018) Translational proteomic study to address host protein changes during aspergillosis. PLOS ONE 13:7, pages e0200843.
Crossref
Crossref
Pham Thi Bich Hanh, Do Thi Thao, Nguyen Thi Nga, Ngo Thi Phuong, Le Ngoc Hung, Do Truong Thien & Le Minh Ha. (2018)
Toxicity and Anti-inflammatory Activities of an Extract of the
Eleutherine bulbosa
Rhizome on Collagen Antibody-induced Arthritis in a Mouse Model
. Natural Product Communications 13:7, pages 1934578X1801300.
Crossref
Crossref
Mayuko Uehara, Zhabiz Solhjou, Naima Banouni, Vivek Kasinath, Ye Xiaqun, Li Dai, Osman Yilmam, Mine Yilmaz, Takaharu Ichimura, Paolo Fiorina, Paulo N. Martins, Shunsuke Ohori, Indira Guleria, Omar H. Maarouf, Stefan G. Tullius, Martina M. McGrath & Reza Abdi. (2018) Ischemia augments alloimmune injury through IL-6-driven CD4+ alloreactivity. Scientific Reports 8:1.
Crossref
Crossref
Leroy Shervington, Ashish Darekar, Murassa Shaikh, Roshini Mathews & Amal Shervington. (2018) Identifying Reliable Diagnostic/Predictive Biomarkers for Rheumatoid Arthritis. Biomarker Insights 13, pages 117727191880100.
Crossref
Crossref
Jayesh Mudgal, S.A. Manohara Reddy, Geetha Mathew, Anoop Kishore, C. Mallikarjuna Rao & Gopalan K. Nampurath. (2018) Heterocyclic homoprostanoid derivative attenuates monoarthritis in rats: An in vitro and in vivo preclinical paradigm. European Journal of Pharmaceutical Sciences 111, pages 320-329.
Crossref
Crossref
Shi-Min An, Hui-Min Lei, Xu-Ping Ding, Fan Sun, Chun Zhang, Ya-Bin Tang, Hong-Zhuan Chen, Ying Shen & Liang Zhu. (2017) Interleukin-6 identified as an important factor in hypoxia- and aldehyde dehydrogenase-based gefitinib adaptive resistance in non-small cell lung cancer cells. Oncology Letters 14:3, pages 3445-3454.
Crossref
Crossref
Juliette Raffort, Fabien Lareyre, Marc Clément, Réda Hassen-Khodja, Giulia Chinetti & Ziad Mallat. (2017) Monocytes and macrophages in abdominal aortic aneurysm. Nature Reviews Cardiology 14:8, pages 457-471.
Crossref
Crossref
Chaman Saini, Mohd Tarique, Reeta Rai, Anisuddin Siddiqui, Neena Khanna & Alpana Sharma. (2017) T helper cells in leprosy: An update. Immunology Letters 184, pages 61-66.
Crossref
Crossref
Lisha Dong, Jinqiu Zhu, Hongzhi Du, Heng Nong, Xicheng He & Xiaoyu Chen. (2017)
Astilbin from
Smilax glabra
Roxb. Attenuates Inflammatory Responses in Complete Freund’s Adjuvant-Induced Arthritis Rats
. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-10.
Crossref
Crossref
Mi-Hwa Kim, Kyungsook Jung, Ki-Hoan Nam, Hyun-Jae Jang, Seung Woong Lee, Yesol Kim, Chan Sun Park, Tae-Hoon Lee, Jee Hun Park, Jung Ho Choi, Mun-Chual Rho & Hyun-Mee Oh. (2016) Salvia plebeia R.Br. inhibits signal transduction of IL-6 and prevents ovariectomy-induced bone loss by suppressing osteoclastogenesis. Archives of Pharmacal Research 39:12, pages 1671-1681.
Crossref
Crossref
Kyung Eun Kim, Sungryung Kim, Sunyoung Park, Younkyung Houh, Yoolhee Yang, Seung Beom Park, Sangyoon Kim, Daejin Kim, Dae Young Hur, Seonghan Kim, Hyun Jeong Park, Sa Ik Bang & Daeho Cho. (2016) Therapeutic effect of erythroid differentiation regulator 1 (Erdr1) on collagen-induced arthritis in DBA/1J mouse. Oncotarget 7:47, pages 76354-76361.
Crossref
Crossref
Soheil Tavakolpour. (2016) Interleukin 21 as a new possible player in pemphigus: Is it a suitable target?. International Immunopharmacology 34, pages 139-145.
Crossref
Crossref
Michael E. Weinblatt, Philip Mease, Eduardo Mysler, Tsutomu Takeuchi, Edit Drescher, Alberto Berman, Jun Xing, Moshe Zilberstein, Subhashis Banerjee & Paul Emery. (2015) The Efficacy and Safety of Subcutaneous Clazakizumab in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results From a Multinational, Phase IIb, Randomized, Double-Blind, Placebo/Active-Controlled, Dose-Ra. Arthritis & Rheumatology 67:10, pages 2591-2600.
Crossref
Crossref
Sarah A. O’Brien, Minghua Zhu & Weiguo Zhang. (2015) The Importance of IL-6 in the Development of LAT-Mediated Autoimmunity. The Journal of Immunology 195:2, pages 695-705.
Crossref
Crossref
Jinyoung MoonNakwon KwakJin LimDong Jin GoJae Hyun LeeJin Kyun ParkEun Bong LeeYeong Wook SongJai Il YounEun Young Lee. (2015) Appearance of Psoriasis after Tumor Necrosis Factor-α Blocker and Use of Ustekinumab or Tocilizumab for Refractory Monoarthritis. Journal of Rheumatic Diseases 22:4, pages 263.
Crossref
Crossref
Daniel FJ Ketelhuth & Göran K Hansson. (2015) Modulation of Autoimmunity and Atherosclerosis – Common Targets and Promising Translational Approaches Against Disease –. Circulation Journal 79:5, pages 924-933.
Crossref
Crossref
Jayesh Mudgal, Vasantharaju S. Gowdra, Geetha Mathew, Pawan G. Nayak, Nitin D. Reddy, Neelesh Namdeo, Ravilla R. Kumar, Chaitanya Kantamaneni, Mallikarjuna R. Chamallamudi & Gopalan K. Nampurath. (2014) Remedial effects of novel 2,3-disubstituted thiazolidin-4-ones in chemical mediated inflammation. Chemico-Biological Interactions 210, pages 34-42.
Crossref
Crossref
Iain B McInnes, Ho-Youn Kim, Sang-Heon Lee, David Mandel, Yeong-Wook Song, Carol A Connell, Zhen Luo, M Julia Brosnan, Andrea Zuckerman, Samuel H Zwillich & John D Bradley. (2014) Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study*. Annals of the Rheumatic Diseases 73:1, pages 124-131.
Crossref
Crossref
Maša Umićević Mirkov & Marieke JH Coenen. (2013) Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine. Pharmacogenomics 14:4, pages 425-444.
Crossref
Crossref
Graeme Meintjes, James Scriven & Suzaan Marais. (2012) Management of the Immune Reconstitution Inflammatory Syndrome. Current HIV/AIDS Reports 9:3, pages 238-250.
Crossref
Crossref
Graeme Meintjes, Keira H. Skolimowska, Katalin A. Wilkinson, Kerryn Matthews, Rebecca Tadokera, Anali Conesa-Botella, Ronnett Seldon, Molebogeng X. Rangaka, Kevin Rebe, Dominique J. Pepper, Chelsea Morroni, Robert Colebunders, Gary Maartens & Robert J. Wilkinson. (2012) Corticosteroid-modulated Immune Activation in the Tuberculosis Immune Reconstitution Inflammatory Syndrome. American Journal of Respiratory and Critical Care Medicine 186:4, pages 369-377.
Crossref
Crossref
Channarong Muangnoi, Pimjai Chingsuwanrote, Phawachaya Praengamthanachoti, Saovaros Svasti & Siriporn Tuntipopipat. (2011) Moringa oleifera Pod Inhibits Inflammatory Mediator Production by Lipopolysaccharide-Stimulated RAW 264.7 Murine Macrophage Cell Lines. Inflammation 35:2, pages 445-455.
Crossref
Crossref
Melania Martínez-Morillo, Dolors Grados, Beatriz Tejera & Alejandro Olivé Marqués. (2011) Inhibidor del receptor de la interleucina-6 en el tratamiento de la artritis reumatoide: seguridad y dosificación del tocilizumab. Seminarios de la Fundación Española de Reumatología 12:2, pages 57-60.
Crossref
Crossref
Lisette Bevaart, Margriet J. Vervoordeldonk & Paul P. Tak. (2010) Evaluation of therapeutic targets in animal models of arthritis: How does it relate to rheumatoid arthritis?. Arthritis & Rheumatism 62:8, pages 2192-2205.
Crossref
Crossref
Robert J. Mourey, Barry L. Burnette, Sarah J. Brustkern, J. Scott Daniels, Jeffrey L. Hirsch, William F. Hood, Marvin J. Meyers, Stephen J. Mnich, Betsy S. Pierce, Matthew J. Saabye, John F. Schindler, Sarah A. South, Elizabeth G. Webb, Jian Zhang & David R. Anderson. (2010) A Benzothiophene Inhibitor of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Inhibits Tumor Necrosis Factor α Production and Has Oral Anti-Inflammatory Efficacy in Acute and Chronic Models of Inflammation. Journal of Pharmacology and Experimental Therapeutics 333:3, pages 797-807.
Crossref
Crossref
Heidi R. Hope, Gary D. Anderson, Barry L. Burnette, Robert P. Compton, Rajesh V. Devraj, Jeffrey L. Hirsch, Robert H. Keith, Xiong Li, Gabriel Mbalaviele, Dean M. Messing, Matthew J. Saabye, John F. Schindler, Shaun R. Selness, Loreen I. Stillwell, Elizabeth G. Webb, Jian Zhang & Joseph B. Monahan. (2009)
Anti-Inflammatory Properties of a Novel
N
-Phenyl Pyridinone Inhibitor of p38 Mitogen-Activated Protein Kinase: Preclinical-to-Clinical Translation
. Journal of Pharmacology and Experimental Therapeutics 331:3, pages 882-895.
Crossref
Crossref
Pradeep Kumar Dagur, Gulnaz Tatlici, Mark Gourley, Leigh Samsel, Nalini Raghavachari, Poching Liu, Delong Liu & J. Philip McCoyJr.Jr.. (2009) CD146+ T lymphocytes are increased in both the peripheral circulation and in the synovial effusions of patients with various musculoskeletal diseases and display pro-inflammatory gene profiles. Cytometry Part B: Clinical Cytometry 9999B, pages NA-NA.
Crossref
Crossref